[S-48] Symposium 48
State-of-the-art basic research for Alzheimer's disease

[S-48-5] Progression of Alzheimer's disease, tau propagation, and tau-targeting therapies

^○Shuko Takeda (Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Japan)

In recent years, many clinical trials for Alzheimer's disease (AD) have ended in disappointment. Now it's time to rethink strategy to defeat AD. In this symposium, researchers at the vanguard of AD basic research will introduce their recent remarkable work, including elucidation of AD pathomechanisms, generation of AD animal models, and establishing new concepts of therapies and biomarkers utilizing cutting-edge technologies. We believe that talk in this session will provide neurologists important insights to gain a better understanding of AD.

Mar. 2004: M.D., Hokkaido University School of Medicine, Japan
Mar. 2010: Ph.D. in Medicine, Graduate School of Medicine, Osaka University, Japan
2004-2006 Resident, Osaka University Hospital, Japan
2011 Assistant Professor, Graduate School of Medicine, The University of Tokyo, Japan
2011-2013 Research Fellowship for Young Scientists PD (Japan Society for the Promotion of Science), Harvard Medical School
2013-2015 Postdoctoral Fellowship for Research Abroad (Japan Society for the Promotion of Science), Harvard Medical School
2015 Research fellow, Harvard Medical School / Massachusetts General Hospital
2016- Associate Professor, Graduate School of Medicine, Osaka University, Japan